Fidelity Investments’s Black Diamond Therapeutics BDTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.03M | Buy |
413,886
+75,217
| +22% | +$187K | ﹤0.01% | 2712 |
|
|
2025
Q1 | $525K | Buy |
338,669
+142,542
| +73% | +$221K | ﹤0.01% | 2882 |
|
|
2024
Q4 | $420K | Buy |
196,127
+17,059
| +10% | +$36.5K | ﹤0.01% | 2995 |
|
|
2024
Q3 | $779K | Buy |
+179,068
| New | +$779K | ﹤0.01% | 2682 |
|
|
2024
Q1 | – | Sell |
-2
| Closed | -$6 | – | 5366 |
|
|
2023
Q4 | $6 | Hold |
2
| – | – | ﹤0.01% | 5357 |
|
|
2023
Q3 | $6 | Sell |
2
-16
| -89% | -$48 | ﹤0.01% | 5211 |
|
|
2023
Q2 | $92 | Sell |
18
-66
| -79% | -$337 | ﹤0.01% | 4969 |
|
|
2023
Q1 | $158 | Buy |
84
+75
| +833% | +$141 | ﹤0.01% | 4868 |
|
|
2022
Q4 | $16 | Sell |
9
-281
| -97% | -$500 | ﹤0.01% | 5164 |
|
|
2022
Q3 | $0 | Buy |
290
+254
| +706% | – | ﹤0.01% | 4854 |
|
|
2022
Q2 | $0 | Sell |
36
-14,622
| -100% | – | ﹤0.01% | 4916 |
|
|
2022
Q1 | $41K | Buy |
14,658
+14,649
| +162,767% | +$41K | ﹤0.01% | 3741 |
|
|
2021
Q4 | $0 | Hold |
9
| – | – | ﹤0.01% | 4335 |
|
|
2021
Q3 | $0 | Sell |
9
-360,420
| -100% | – | ﹤0.01% | 4341 |
|
|
2021
Q2 | $4.39M | Sell |
360,429
-1,730,859
| -83% | -$21.1M | ﹤0.01% | 2364 |
|
|
2021
Q1 | $50.7M | Buy |
2,091,288
+429,631
| +26% | +$10.4M | ﹤0.01% | 1396 |
|
|
2020
Q4 | $53.3M | Buy |
1,661,657
+264,005
| +19% | +$8.46M | ﹤0.01% | 1291 |
|
|
2020
Q3 | $42.3M | Sell |
1,397,652
-27,283
| -2% | -$825K | ﹤0.01% | 1261 |
|
|
2020
Q2 | $60.1M | Sell |
1,424,935
-163,075
| -10% | -$6.88M | 0.01% | 1088 |
|
|
2020
Q1 | $39.6M | Buy |
+1,588,010
| New | +$39.6M | 0.01% | 1120 |
|